Biodel

From WikiCover

Biodel is a development stage specialty biopharmaceutical company located in Danbury, Connecticut. The company is focused on the development and commercialization of innovative treatments for endocrine disorders, such as diabetes and osteoporosis. Biodel develops product candidates by applying proprietary formulation technologies to existing drugs in order to improve their therapeutic results. Biodel has two insulin product candidates currently in clinical trials for the treatment of diabetes (including injectable human insulin). Additionally, the company has two preclinical product candidates for the treatment of osteoporosis.